Neonatal onset atypical hemolytic uremic syndrome successfully treated with eculizumab

Neonatal atypical hemolytic uremic syndrome due to methylmalonic aciduria and homocystinuria

(2012) Francesca Menni et al.   PEDIATRIC NEPHROLOGY

Eculizumab in the Treatment of Atypical Hemolytic Uremic Syndrome in Infants

(2011) Gema Ariceta et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Atypical hemolytic uremic syndrome

(2011) Chantal Loirat et al.   Orphanet Journal of Rare Diseases

Genetics and complement in atypical HUS

(2010) David Kavanagh et al.   PEDIATRIC NEPHROLOGY

Efficacy of eculizumab in a patient with factor-H-associated atypical hemolytic uremic syndrome

(2010) Anne-Laure Lapeyraque et al.   PEDIATRIC NEPHROLOGY

aHUS caused by complement dysregulation: new therapies on the horizon

(2010) Aoife M. Waters et al.   PEDIATRIC NEPHROLOGY

New Treatment Options for Atypical Hemolytic Uremic Syndrome with the Complement Inhibitor Eculizumab

(2010) Özlem Köse et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome

(2009) I. Moore et al.   BLOOD

Complement Inhibitor Eculizumab in Atypical Hemolytic Uremic Syndrome

(2009) C. J. Mache et al.   Clinical Journal of the American Society of Nephrology

Clinical practice

(2009) Johanna Scheiring et al.   EUROPEAN JOURNAL OF PEDIATRICS

Eculizumab for Congenital Atypical Hemolytic–Uremic Syndrome

(2009) Ralph A. Gruppo et al.   NEW ENGLAND JOURNAL OF MEDICINE

Thrombomodulin Mutations in Atypical Hemolytic–Uremic Syndrome

(2009) Mieke Delvaeye et al.   NEW ENGLAND JOURNAL OF MEDICINE